- Home
- HUMAW vs REVG Comparison
HUMAW vs REVG Comparison
Compare HUMAW & REVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMAW
- REVG
- Stock Information
- Founded
- HUMAW 2004
- REVG 2008
- Country
- HUMAW United States
- REVG United States
- Employees
- HUMAW 185
- REVG N/A
- Industry
- HUMAW Biotechnology: Pharmaceutical Preparations
- REVG Auto Manufacturing
- Sector
- HUMAW Health Care
- REVG Consumer Discretionary
- Exchange
- HUMAW Nasdaq
- REVG Nasdaq
- Market Cap
- HUMAW N/A
- REVG N/A
- IPO Year
- HUMAW N/A
- REVG 2017
- Fundamental
- Price
- HUMAW $0.34
- REVG $31.13
- Analyst Decision
- HUMAW
- REVG Hold
- Analyst Count
- HUMAW 0
- REVG 4
- Target Price
- HUMAW N/A
- REVG $33.75
- AVG Volume (30 Days)
- HUMAW 14.2K
- REVG 903.6K
- Earning Date
- HUMAW 03-21-2025
- REVG 06-04-2025
- Dividend Yield
- HUMAW N/A
- REVG 0.77%
- EPS Growth
- HUMAW N/A
- REVG N/A
- EPS
- HUMAW N/A
- REVG 1.77
- Revenue
- HUMAW N/A
- REVG $2,319,300,000.00
- Revenue This Year
- HUMAW N/A
- REVG $2.51
- Revenue Next Year
- HUMAW N/A
- REVG $6.97
- P/E Ratio
- HUMAW N/A
- REVG $17.73
- Revenue Growth
- HUMAW N/A
- REVG N/A
- 52 Week Low
- HUMAW $1.18
- REVG $20.86
- 52 Week High
- HUMAW $1.34
- REVG $36.00
- Technical
- Relative Strength Index (RSI)
- HUMAW N/A
- REVG 50.91
- Support Level
- HUMAW N/A
- REVG $28.49
- Resistance Level
- HUMAW N/A
- REVG $32.55
- Average True Range (ATR)
- HUMAW 0.00
- REVG 1.75
- MACD
- HUMAW 0.00
- REVG -0.03
- Stochastic Oscillator
- HUMAW 0.00
- REVG 73.46
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.